You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company will bring its Mastermind genomic search engine to clinical labs in China, where early tests have shown a sharp reduction in VUS search time.
Michigan-based Advaita Bioinformatics wants to be a one-stop shop for proteomics, transcriptomics, and variant analysis, as well as internet omics search.
French startup OmicX has built an AI-based search engine for omics-related knowledge to help biomedical researchers find protocols in published literature.
LifeMap says that the newly announced partnership will improve literature searches for users of its GeneCards knowledge base and TGex clinical genomics platform.
With VarSome's search function, Saphetor wants to link geneticists and clinicians and "everything to everything else" in its database.
The Genomenon Mastermind genomic search engine links to Saphetor's VarSome genomic annotation tool, while VarSome links back to variant-related literature.
One app identifies off-target sites in gene editing experiments while a second app generates a ranked list of CRISPR designs based on gene location and other information.
DNAstack offers cloud-based access to bioinformatics solutions and mechanisms for sharing genomic data that leverage open APIs and resources.
Under the terms of the agreement, Ariadne will provide its MedScan literature-mining technology to Quertle. In exchange, Ariadne will package Quertle's semantic search engine as an appliance solution for its customers.
Bioinformatics Tool-Related Papers of Note, February 2009
AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.
Time magazine looks into how liquid biopsies are changing cancer care.
According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.
In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.